XML 60 R38.htm IDEA: XBRL DOCUMENT v3.25.1
Stock Option Plans (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of the assumptions employed in the calculation of the fair value of share-based compensation expense

The Company uses the Black-Scholes option pricing model to estimate the fair value of stock-based awards on the date of grant. The assumptions employed in the calculation of the fair value of share-based compensation expense were calculated as follows for all periods presented:

 

 

 

 

2024

 

 

2023

 

Common stock fair value

 

 

$

4.76

 

 

$

3.69

 

Risk free interest rate

 

 

4.10% - 4.35%

 

 

4.05% - 4.89%

 

Expected dividend yield

 

 

0%

 

 

0%

 

Expected term

 

 

6.0 years

 

 

4.9 years

 

Expected stock volatility

 

 

100.1% - 103.0%

 

 

91.9% - 99.7%

 

Schedule of below is a summary of stock option activity

Below is a summary of stock option activity for the year ending December 31, 2024:

 

 

 

 

 

Weighted

 

 

Weighted

 

Number

 

 

Average

 

 

Average

 

of options

 

 

Exercise Price

 

 

Contractual Life

Outstanding at December 31, 2023

 

2,781,064

 

 

$

2.97

 

 

4.43 years

Options assumed from Kintara upon merger closing

 

6,345

 

 

$

1,074.40

 

 

6.91 years

Forfeited and cancelled

 

(249,961

)

 

$

3.53

 

 

 

Exercised

 

(180,689

)

 

$

2.66

 

 

 

Granted

 

4,047,059

 

 

$

4.76

 

 

 

Outstanding at December 31, 2024

 

6,403,818

 

 

$

5.11

 

 

7.44 years

Exercisable at December 31, 2024

 

2,270,626

 

 

$

5.83

 

 

3.30 years

Summary of activity related to RSUs The table below summarizes activity related to RSUs.

 

 

 

 

Number of RSU

 

Restricted stock units assumed from Kintara upon merger closing

 

 

 

114

 

Vesting of restricted stock units

 

 

 

-

 

Balance as of December 31, 2024

 

 

 

114

 

Summary of total stock-based compensation expense

Total stock-based compensation expense was allocated as follows:

 

 

 

 

2024

 

 

2023

 

General and administrative

 

 

$

843,111

 

 

$

300,986

 

Research and development

 

 

 

1,115,552

 

 

 

177,904

 

Total stock-based compensation expense

 

 

$

1,958,663

 

 

$

478,890